Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial.

Oselinsky KM, Hill EB, Ostendorf DM, Pan Z, Bing K, Wayland LT, Simpson C, Clark KC, Sandoval A, Thomas EA, Marker RJ, Kabos P, MacLean PS, Catenacci VA

Open source

DOI
10.2196/86281
Published
2026 Jul 23
Container
JMIR research protocols
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2196/86281,
  title = {Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial.},
  author = {Oselinsky KM and Hill EB and Ostendorf DM and Pan Z and Bing K and Wayland LT and Simpson C and Clark KC and Sandoval A and Thomas EA and Marker RJ and Kabos P and MacLean PS and Catenacci VA},
  year = {2026},
  journal = {JMIR research protocols},
  doi = {10.2196/86281},
  url = {https://doi.org/10.2196/86281}
}

RIS

TY  - JOUR
TI  - Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial.
AU  - Oselinsky KM
AU  - Hill EB
AU  - Ostendorf DM
AU  - Pan Z
AU  - Bing K
AU  - Wayland LT
AU  - Simpson C
AU  - Clark KC
AU  - Sandoval A
AU  - Thomas EA
AU  - Marker RJ
AU  - Kabos P
AU  - MacLean PS
AU  - Catenacci VA
PY  - 2026
JO  - JMIR research protocols
DO  - 10.2196/86281
UR  - https://doi.org/10.2196/86281
ER  - 

APA

KM, O., EB, H., DM, O., Z, P., K, B., LT, W., C, S., KC, C., A, S., EA, T., RJ, M., P, K., PS, M., & VA, C. (2026). Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial.. JMIR research protocols. https://doi.org/10.2196/86281

Source records